The global medical industry experienced a 19% drop in company filings mentions of Covid-19 in Q3 2022 compared with the previous quarter, with the highest share accounted for by Hologic with 61% year-on-year decrease, according to GlobalData’s analysis of over 706 medical company filings.

Notably, Covid-19 was one of the most frequently referenced themes in Q3 2022, ranking highest in terms of mentions, ahead of digitalization and 3d printing, according to GlobalData.

Of the 50 leading companies in the medical industry, Hologic had the greatest increase in references for Covid-19 in Q3 2022, compared with the previous quarter. GlobalData identified 80 Covid-19-related sentences in the company's filings - 11% of all sentences - and an increase of 17% in Q3 2022 compared with Q2 2022. Quest Diagnostics’s mentions of Covid-19 dropped by 11% to 79 and DexCom’s by 9% to 78.

GlobalData’s Company Filings Analytics also applies sentiment weight to reference sentences, based on whether the sentences are positive, negative, or neutral. Starting at 100 in 2020, an index over 100 is more positive. The overall index for Covid-19 in Q3 2022 was 131.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Company Filings Analytics uses machine learning to uncover key insights and track sentiment across millions of regulatory filings and other corporate disclosures for thousands of companies across the world’s largest industries.